Table 2.
Nonuse | Current use |
|||
---|---|---|---|---|
Variable | < 2 years | ≥ 2 yearsc | Total | |
Cases | 2,412 | 113 | 54 | 167 |
Person-years | 283,633 | 13,907 | 7,657 | 21,564 |
Model 1: Age-adjusted (95% C.I.)b |
1.00 (referent) |
0.97 (0.80, 1.18) |
0.93 (0.71, 1.22) |
0.96 (0.82, 1.12) |
Model 2: Multivariate (95% C.I.)b |
1.00 (referent) |
0.83 (0.68, 1.01) |
0.81 (0.62, 1.06) |
0.82 (0.70, 0.96) |
Model 2: Relative risk adjusting for age, time period, body mass index at the beginning of each two-year follow-up interval, weight change in the previous two years, parity, oral contraceptive use, hormone replacement therapy, physical activity, pack-years of smoking, thiazide diuretics, non-steroidal anti-inflammatory drugs, intake of total energy, energy-adjusted dietary fiber, energy-adjusted protein, energy-adjusted carbohydrate, alcohol, coffee, saturated fat, trans fat, and polyunsaturated fat.
Retrospective assessment between 1994 and 2000
C.I. = confidence interval.
The categories of 2-4 years and >4 years were collapsed into one category due to few cases in the category of >4 years.